PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
23-Nov-2021 Caixa Capital Risc leads sale of Sanifit Therapeutics to Vifor Pharma with upfront payment of €205M Andrew Lloyd Associates
22-Nov-2021 Pistoia Alliance predicts a focus on the fight against antimicrobial resistance and a surge in quantum computing research for 2022 Pistoia Alliance
22-Nov-2021 Deciphera obtient l’autorisation de la Commission européenne pour le Qinlock® (ripretinib) en traitement de quatrième ligne des tumeurs stromales gastro-intestinales (GIST) Andrew Lloyd Associates
22-Nov-2021 Amerigo Scientific Announces Offering of Human Plasmin, Recombinant Amerigo Scientific
22-Nov-2021 Amerigo Scientific Launches Soluble Collagen for Cell Culture Amerigo Scientific
22-Nov-2021 CD Bioparticles Introduces Customizable MOFs Linkers for Research Use CD Bioparticles
22-Nov-2021 Amerigo Scientific Launches Human Pro-Glu-Plasminogen, Recombinant for Research Use Amerigo Scientific
22-Nov-2021 CD Bioparticles Announces Spherical Titania Nanoparticles CD Bioparticles
22-Nov-2021 STEMart Introduces Medical Device Risk Assessments Services STEMart
18-Nov-2021 mRNA Victoria and Ginkgo Bioworks Announce Partnership to Grow the Bioeconomy & International Biosecurity Capabilities mRNA Victoria
18-Nov-2021 Aglaia Therapeutics becomes Ribonexus and signs exclusive license agreement with Pierre Fabre on small molecules targeting eIF4A, an innovative target in oncology Andrew Lloyd Associates
17-Nov-2021 Lynred boosts thermal sensitivity across range of 12-micron infrared detectors Andrew Lloyd Associates
17-Nov-2021 Moderna Announces European Union and European Economic Area Countries to Donate More than 70 Million Doses of Moderna COVID-19 Vaccine to COVAX in 2021 to Help End COVID-19 Pandemic in Low Income Countries Moderna
15-Nov-2021 Antios Therapeutics Announces Agreement with IRBM, INGM and OSR to Acquire Fourth-Generation HBV Capsid Assembly Modulators (CAMs) IRBM
08-Nov-2021 Genoskin appoints Dr Nicolas Gaudenzio as Chief Scientific Officer Andrew Lloyd Associates
05-Nov-2021 Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services Aragen
05-Nov-2021 CPhI Worldwide Report: CMOs will account for four of the five top bio manufacturing capacities in 2025 CPhI Worldwide
03-Nov-2021 Biomunex Pharmaceuticals’ breakthrough immunotherapy project receives grants close to €3 million Andrew Lloyd Associates
03-Nov-2021 Minafin’s health chemistry division launches Blendamix, custom powder premix manufacturing service for food and pharma applications Andrew Lloyd Associates
02-Nov-2021 ‘Pick and mix’ technology promises future-proof universal vaccines against COVID and more Baseimmune